Today's Veterinary Practice partnered with the NAVC's VetFolio Voice to produce podcast interviews based on select articles from the journal, giving working DVMs a way to get specialist-level CE content without blocking out time to read.
The podcast series features Cassi Fleming, MS, DVM, interviewing veterinary specialists about topics covered in the journal's Ask a Specialist articles. Topics to date include "Cracking the Capnography Code" and "Practical Tips for Demystifying the Orthopedic Exam." The source describes the interviews as deep dives of select articles. The journal also launched a LinkedIn presence for article distribution.
The audio format and what it changes
The podcast gives the journal a second distribution channel for the same editorial work, and the specialist interview format keeps the content clinical rather than promotional. We're watching whether the audio format reaches associate DVMs who say they want more CE but don't have time to read. The format is right for that problem, but execution matters.
The LinkedIn distribution gives readers another place to find new articles and potentially older archive material that still applies. Our read: the podcast is the real move, the LinkedIn page is table stakes.
If your week runs on calls like this one, subscribe to VeterinaryPracticeNow.
For working DVMs
The podcast series gives associate DVMs a way to stay current on specialist topics without blocking out time to read, and that matters when you are between appointments. If you own the practice and are deciding whether to add continuing education resources for your associates, the podcast format is a candidate if your team is asking for more CE but does not have the bandwidth to read full articles.
The journal also published a review titled "Role of the Microbiota-Gut-Brain Axis in Behavioral and Neurologic Disorders" in the same issue. According to the source, gastrointestinal bacteria secrete neuroactive substances, including neurotransmitters, short-chain fatty acids, and amino acids, and the influence of bacteria on emotions, cognition, and behavior has led to recognition of the microbiota-gut-brain axis. The source says the microbiome appears to be a promising therapeutic target and that recognizing its long history helps see this as more than a trend. The review is biological context, not a clinical protocol. The axis exists and researchers think it matters, but the review does not give you the decision tree for when to pursue microbiome-based approaches in a behavioral or neurologic case.